The magnitude of this cluster buy (4.7% of market cap from two 10% owners) is a strong bullish signal at a micro-cap with no analyst support. Monitor for upcoming press releases, pipeline updates, or financing announcements, the insiders may be positioning ahead of material news. The stock's low liquidity means even small volume could amplify moves.
INM drugs
INM drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 11 $1.58entry
- T+1 · 5mo ago −4.43%α −4.97% · $1.51
- T+5 · 5mo ago −5.70%α −6.13% · $1.49
- T+20 · 4mo ago +5.06%α +3.17% · $1.66
- T+60 · 2mo ago −12.66%α −17.05% · $1.38
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two 10% owners (Vivo Opportunity, LLC and ADAR1 Capital Management, LLC) purchased a combined $189K of INM stock in an 8-day window, representing ~4.7% of the company's $4M market cap. This is a highly material cluster buy from sophisticated investors at a micro-cap pharma with no analyst bullish coverage, suggesting conviction ahead of a potential catalyst.
Key Financial Metrics
Key Facts
- Two 10% owners bought $189K total in open-market purchases over 8 days (May 13–20, 2026).
- Total buy value equals ~4.7% of INM's $4M market cap, far exceeding the 2% materiality threshold.
- Vivo Opportunity, LLC bought 51.1K shares at $1.56 ($80K) on May 20.
- ADAR1 Capital Management, LLC bought 68.6K shares at $1.60 ($110K) on May 19.
- INM has zero analyst buy ratings (3 Hold, 5 Sell/Strong Sell) and a $4M market cap.
Financial Impact
$189K in insider purchases = 4.7% of $4M market cap
Risk Factors
- Micro-cap pharma with $4M market cap is highly speculative and illiquid.
- No analyst bullish coverage and 5 sell/strong sell ratings indicate fundamental challenges.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INM-1781140524722 |
Track record
22 reports on INM
5 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +24.51% at T+1 after the Nov 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K Neutral 5/10 Entry $16.00 Now $19.87 +24.19% settles Dec 8
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $13.21 Now $19.87 +50.42% settles Dec 4
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $13.21 Now $19.87 +50.42% settles Dec 4
- Nov 3, 202613d ago 8-K Bearish 6/10 Entry $1.75 Now $19.87 −1035.43% settles Dec 3
- Nov 2, 202614d ago 425 Neutral 3/10 Entry $1.68 Now $19.87 +1082.74% settles Dec 2
- Oct 26, 202621d ago 425 Neutral 3/10 Entry $1.59 Now $19.87 +1149.69% settles Nov 24
- Oct 7, 20265w ago SC 13G/A Bullish 5/10 Entry $1.33 to $1.32 Now $19.87 +1393.99% ▼ −0.68% +4.61% vs SPY
- Oct 2, 20266w ago EFFECT Neutral 3/10 Entry $1.33 to $1.60 Now $19.87 +1393.99% ▲ +20.30% +22.11% vs SPY
- Sep 18, 20268w ago 8-K Bearish 6/10 Entry $1.38 to $1.37 Now $19.87 −1339.86% ▲ +1.06% +0.15% vs SPY
- Sep 9, 20269w ago 425 Neutral 6/10 Entry $1.31 to $1.33 Now $19.87 +1416.79% ▲ +1.53% −0.60% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers